Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients
Anticancer Research · 2023
DOI: 10.21873/anticanres.16286 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2023. Verfasst von Yen-Hao Chen und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicin…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, R.O.C.; alex8701125@gmail.com.
- School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan, R.O.C.
- School of Medicine, Chung Shan Medical University, Taichung, Taiwan, R.O.C.
- Department of Nursing, School of Nursing, Fooyin University, Kaohsiung, Taiwan, R.O.C.
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, R.O.C.
- Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan, R.O.C.
Zitieren
APA
Chen, Y. H., Chen, Y. Y., Wang, J. H., & Hung, C. H. (2023). Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients. Anticancer Research. https://doi.org/10.21873/anticanres.16286
Vancouver
Chen YH, Chen YY, Wang JH, Hung CH. Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients. Anticancer Research. 2023. doi:10.21873/anticanres.16286
BibTeX
@article{Chen2023,
author = {Chen, Yen-Hao and Chen, Yen-Yang and Wang, Jing-Houng and Hung, Chao-Hung},
title = {Efficacy and Safety of Lenvatinib After Progression on First-line Atezolizumab Plus Bevacizumab Treatment in Advanced Hepatocellular Carcinoma Patients},
journal = {Anticancer Research},
year = {2023},
doi = {10.21873/anticanres.16286}
}
EUVIMED